CONTENTS:
- Helping smokers quit: New partners and new strategies from the University of California, San Francisco Smoking Cessation Leadership Center. Schroeder S.A., Clark B., Cheng C., Saucedo C.B., p. 3-11.
- Feasibility and preliminary effectiveness of varenicline for treating co-occurring cannabis and tobacco use. Adams T.R., Arnsten J.H., Ning Y.M., Nahvi S., p. 12-18.
- Regulating cannabis manufacturing: Applying public health best practices from tobacco control. Orenstein D.G., Glantz S.A., p. 19-32.
- Rash impulsiveness and negative mood, but not alexithymia or reward sensitivity, differentiate young to middle-aged chronic daily smokers from never-smokers. Lyvers M., Bremner M., Edwards M.S., Thorberg F.A., p. 33-42.
- Alcohol and drug use, pain and psychiatric symptoms among adults seeking outpatient psychiatric treatment: Latent class patterns and relationship to health status. Ramo D.E., Bahorik A.L., Delucchi K.L., Campbell C.I., Satre D.D., p. 43-53.
- Correlates of high-risk and low-risk alcohol use among college students in Kerala, India. Jaisoorya T.S., Gowda G.S., Nair B.S., Menon P.G., Rani A., Radhakrishnan K.S., et al., p. 54-61.
- Perceived treatment need and latent transitions in heroin and methamphetamine polydrug use among people who inject drugs in Tijuana, Mexico. Meacham M.C., Roesch S.C., Strathdee S.A., Gaines T.L., p. 62-71.
- Mortality trends among cocaine users treated between 1989 and 2013 in Northern Italy: Results of a longitudinal study. Pavarin R.M., Fioritti A., p. 72-80.
- Experiential avoidance and bulimic symptoms among men in residential treatment for substance use disorders: A preliminary examination. Elmquist J., Shorey R.C., Anderson S., Stuart G.L., p. 81-87.
- What's in a name? Correlates of ecstasy users knowing or agreeing that Molly is ecstasy/MDMA. Palamar J.J., p. 88-93.